STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

Phase 3positiveLSD therapyPositive

AI Analysis

Summary

Definium Therapeutics reported positive Phase 3 trial results showing its LSD therapy significantly eased anxiety in patients with generalized anxiety disorder in the first of two large-scale trials.

Clinical Trial Data

Phase

Phase 3

Primary Endpoint

Met

Outcome Details

LSD therapy significantly helped patients with generalized anxiety disorder in the first of two large trials

Importance:7/10

Sentiment:

0.70

psychedelicsanxietyPhase 3clinical trial

Related Companies

$TRAX

Read the original article

Published by STAT News on August 12, 2026 12:01 PM

Read Original